DGX

Quest Diagnostics Incorporated
$234.91
-0.09 (-0.04%)
Mkt Cap 25.93B
Volume 864,326
52W Range 171.18-248.84
Sector Healthcare
Beta 0.54
EPS (TTM) 9.54 USD
P/E Ratio 24.62
Revenue (TTM) 11.56B USD
Rev Growth (5Y) +3.2%
EPS Growth (5Y) -3.6%
AlphaVal · Fair Value
What we estimate one share is worth
$131.25
Overvalued strong signal
79.0% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
62.3 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 11.04B 9.87B 9.25B 9.88B 10.79B 9.44B 7.73B 7.53B 7.71B 7.51B 7.49B 7.43B
Net Income 992.00M 871.00M 854.00M 946.00M 2.00B 1.43B 858.00M 736.00M 772.00M 645.00M 709.00M 556.00M
EPS 8.87 7.80 7.59 8.12 15.90 10.68 6.38 5.41 5.63 4.58 4.92 3.83
Free Cash Flow 1.36B 909.00M 864.00M 1.31B 1.83B 1.59B 843.00M 817.00M 923.00M 776.00M 547.00M 630.00M
FCF / Share 12.24 8.19 7.71 11.33 14.64 11.84 6.29 6.01 6.74 5.54 3.80 4.34
Operating CF 1.89B 1.33B 1.27B 1.72B 2.23B 2.00B 1.24B 1.20B 1.18B 1.07B 810.00M 938.00M
Total Assets 16.23B 16.15B 14.02B 12.84B 13.61B 14.03B 12.84B 11.00B 10.50B 10.10B 9.96B 9.88B
Total Debt 6.92B 7.09B 5.50B 4.71B 4.77B 4.81B 5.42B 3.99B 3.85B 3.73B 3.65B 3.76B
Cash & Equiv 420.00M 549.00M 686.00M 315.00M 872.00M 1.16B 1.19B 135.00M 137.00M 359.00M 133.00M 192.00M
Book Value 7.17B 6.78B 6.31B 5.89B 6.44B 6.76B 5.64B 5.22B 4.92B 4.63B 4.68B 4.30B
Return on Equity 0.14 0.13 0.14 0.16 0.31 0.21 0.15 0.14 0.16 0.14 0.15 0.13
DGX News
Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension
Oct 19, 2026 03:57 AM · prnewswire.com
Critical Review: Quest Diagnostics (NYSE:DGX) & Cigna Group (NYSE:CI)
Oct 17, 2026 10:15 PM · defenseworld.net
Dividend Champion, Contender, And Challenger Highlights: Week Of October 18
Oct 16, 2026 02:01 PM · seekingalpha.com
Analyzing Mangoceuticals (NASDAQ:MGRX) & Quest Diagnostics (NYSE:DGX)
Oct 15, 2026 10:59 PM · defenseworld.net
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
Oct 14, 2026 06:16 AM · zacks.com
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Oct 09, 2026 06:41 AM · zacks.com
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Eastern Bank
Oct 05, 2026 09:14 AM · defenseworld.net
Dividend Champion, Contender, And Challenger Highlights: Week October 4
Oct 02, 2026 02:18 PM · seekingalpha.com
Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
Oct 01, 2026 04:52 AM · prnewswire.com
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
Sep 25, 2026 05:15 AM · zacks.com